Skip to main content

Peer Review reports

From: Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograft

Original Submission
31 May 2017 Submitted Original manuscript
25 Sep 2017 Author responded Author comments - Philipp Moog
Resubmission - Version 2
25 Sep 2017 Submitted Manuscript version 2
19 Jan 2018 Author responded Author comments - Philipp Moog
Resubmission - Version 3
19 Jan 2018 Submitted Manuscript version 3
24 Feb 2018 Reviewed Reviewer Report - Nicolae Leca
26 Feb 2018 Reviewed Reviewer Report - Lorraine Racusen
23 Mar 2018 Author responded Author comments - Philipp Moog
Resubmission - Version 4
23 Mar 2018 Submitted Manuscript version 4
1 Apr 2018 Reviewed Reviewer Report - Nicolae Leca
18 Apr 2018 Author responded Author comments - Philipp Moog
Resubmission - Version 5
18 Apr 2018 Submitted Manuscript version 5
Publishing
22 Apr 2018 Editorially accepted
3 May 2018 Article published 10.1186/s12882-018-0904-7

You can find further information about peer review here.

Back to article page